Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Transfer of EAB Group’s own shares

EAB Group Plc, Stock Exchange Release, 6 November 2019, 3:30 p.m. (EET) Transfer of EAB Group’s own shares On 6 November 2019, EAB Group Plc transferred a total of 3,247 own shares held by the company to the key employees of the company without consideration. The transfer is related to the payment of deferred variable remuneration and is in accordance with the Company's remuneration scheme. The regulation requires that, to the extent that a reward scheme for so-called risk-takers may result in a variable remuneration of more than €50,000 per calendar year, at least 40% of the

Orkla ASA: Issuance of Commercial Paper

Orkla ASA has issued a commercial paper of NOK 300,000,000. Start date:                  11 November 2019Maturity:                     11 December 2019Coupon:                     1.73 %Organised by:             Handelsbanken Markets       Orkla ASAOslo, 6 November 2019 Ref.: Senior Vice President Group TreasuryGeir SolliTel.: +47 995 42 789 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Alligator Bioscience: ATOR-1017 Induces Long-Lasting Immunity – New Preclinical Data to be presented at SITC 34th Annual Meeting

Lund, Sweden, November 6, 2019 – Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced that the company will present new preclinical data showing that their drug candidate ATOR-1017 can induce a long-lasting immunological memory which is of great importance in a potential future patient setting. The results will be presented at the ongoing Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting. The ATOR-1017 drug candidate is in development for the treatment of metastasized cancer. Furthermore, the results show that treatment with ATOR-1017 activates the immune system

Saab’s New Electronic Attack Jammer Pod in the Air

Saab carried out the first flight tests with its new advanced Electronic Attack Jammer Pod (EAJP) with successful results on 4 November 2019. The pod’s interfaces with the aircraft’s hardware and software as well as cockpit control and monitoring were tested during the flight.The purpose of Saab’s new EAJP pod is to protect aircraft against radars by sophisticated jamming functions, thereby blocking the opponent’s ability to attack them. The first flight marks an important step of the pod’s development programme. Saab is sharpening its electronic attack capabilities and the new advanced

STRAX: URBANISTA CONTINUES TO DELIVER

Urbanista, the lifestyle audio brand owned by STRAX, continues its path towards a record year in 2019.Following the success of the true wireless headphones Stockholm which remains one of the fundamental products in the Urbanista product portfolio, Urbanista has this fall launched two additional true wireless headphones – Paris and Athens – as well as two true wireless speakers – Sydney and Brisbane – all addressing the true wireless opportunity, the fast growing market segment of the global audio industry. During the year Urbanista has entered into several important collaborations, for

InCoax Networks AB (publ) announces the results of the rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.The subscription period for the new share issue in InCoax Networks AB (publ) (“InCoax” or the “Company”) with preferential rights for existing shareholders (the “Rights Issue”) was completed on November 1, 2019. The outcome of the Rights Issue, which was covered by subscription and guarantee commitments corresponding to 80

TrustShield™, Ahlstrom-Munksjö’s single-use medical fabrics for ultimate protection in the operating room, clinical environment and laboratory

AHLSTROM-MUNKSJÖ, PRESS RELEASE, NOVEMBER 6, 2019 at 2:30 P.M. EET Ahlstrom-Munksjö announces the launch of TrustShield™, a versatile portfolio of medical fabrics that can be used to provide protection against surgical lasers, chemicals and potent chemotherapy drugs. TrustShield™ products were specially designed around growing market trends. The evolution of laser technology in a surgical environment has significantly advanced as their usage has become widespread for numerous specialties. Although there are many benefits to using lasers for surgical procedures, there are also risks.

Invitation to 3Q 2019 presentation

Otello Corporation ASA is presenting its 3Q 2019 results on Wednesday, November 13, 2019, at 08:00am CET. The presentation will take place at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway. A live webcast will be available at: https://otellocorp.com/ir   Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com   About Otello: Otello holds shares in several different businesses, including (i)AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for their businesses, capitalizing on

TOMRA: SUCCESSFUL ISSUANCE OF UNSECURED BONDS

Reference is made to the Q3-presentation and announcement dated 21 October 2019 regarding contemplated bond issue. TOMRA Systems ASA has today successfully issued a total amount of NOK 1,000m in senior unsecured bonds. The transaction is split in two tranches, both were significantly oversubscribed: - 3Y FRN: NOK 400m with a coupon of 3m Nibor + 0.50 % p.a. - 5Y FRN: NOK 600m with a coupon of 3m Nibor + 0.75 % p.a. The net proceeds will be used for general corporate purposes, including refinancing of existing debt. The settlement date is 14 November 2019 and the bonds will be

Kindred - winner of Sweden´s Best Looking Office

Kindred Group is the proud winner of ‘Sweden´s Best Looking Office’. The competition puts the spotlight on companies that have successfully combined aesthetic and compelling environments with a smart and flexible working space adapted to fit the organisations specific needs. Kindred Group moved into its award-winning, purpose-built facility in April this year.Kindred Group (former Unibet Group) is the proud winner of Sweden´s Best Looking Office. A competition arranged annually by Fastighetssverige and Lokalnytt.se.  Kindred moved into their new office at Urban Escape in central Stockholm

Dicot signs Agreement for Contract Research with Pelvipharm

November 6, 2019, Uppsala, Sweden – Dicot AB (publ) (“Dicot” or the “Company”) announced today that the company has entered into a research collaboration agreement with Pelvipharm, a world-leading contract research organization (CRO) based in France. This research collaboration is focused on the identification of Libiguin’s® mechanisms of action, which is a key step towards defining the exact domain for clinical use of the drug, and to support its registration as an approved drug. Pelvipharm specializes in the field of male and female sexual dysfunctions, offering both in vivo and in

Nexam Chemical presents the third quarter for 2019 on November 12 th at 11:00 CET

Nexam Chemical will publish the interim report for the third quarter 2019 on November 12th, 2019 at 08:30 CET. The report and the presentation  will be available at the company website.In connection with the release - analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CET where Johan Arvidsson, CEO will present and comment the report. The presentation will be held in Swedish via a conference call or audio webcast at https://financialhearings.com/event/11856. If you do not intend

Peab renovates and extends school in Norway

Eikeli High School in Bærum, Norway is going to be renovated and extended. Peab has been commissioned to do the work by AFK eiendom FKF and the contract is worth NOK 193 million.Peab is going to renovate around 2,100 m2 of the existing school that was built in 1960. As part of the contract Peab will also build a new 4,500 m2 school building. “Peab has invested a great deal in public projects concerning care, health, schools and education. This project is a result of our initiative and we will be building up vital experience for future projects like this one,” says Trond Ormstad, Region

Metsä Board Corporation: Managers’ transactions

Metsä Board Corporation Managers’ transactions 6 November 2019 at 12 noon EETMetsäliitto Cooperative, which is a closely associated party to Metsä Board’s chairman and two members of the Board, has acquired on 1 November Metsä Board Corporation’s B shares. Metsä Board Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Metsäliitto Osuuskunta Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Hämälä Ilkka Position: Member

Cimco Marine AB (publ) has completed directed share issue of SEK 17,2 million

The directed share issue in Cimco Marine AB (publ) (“Cimco”) resolved by the board of directors on 24 October 2019, as authorized by the annual general meeting on 14 May 2019, has been fully subscribed. A total of 11,451,369 shares have been subscribed for by the guarantee consortium that entered into guarantee commitments in connection with the exercise period for the warrants of series 2019:1. Through the directed share issue, Cimco receives approximately SEK 17,2 million.The new shares were issued at a subscription price of SEK 1.50 per share. The subscription price for the new shares is

NORDEN initiates share buy-back programme

ANNOUNCEMENT NO. 17 - 6 NOVEMBER 2019 The Board of Directors has decided to carry out a share buy-back of up to a total of USD 10 million (approximately DKK 67 million). The share buy-back programme is initiated pursuant to the authorisation granted to the Board of Directors, which entitles NORDEN to acquire treasury shares at a nominal value not exceeding 10% of the share capital at the market price applicable at the time of acquisition with a deviation of up to 10%. This authorisation was most recently renewed at NORDEN’s general meeting on 11 April 2019. PurposeThe purpose of the

IRLAB’s drug candidates IRL942 and IRL1009 have been granted patents in the US and Europe

IRLAB announced today that drug candidates IRL942 and IRL1009 have been granted composition of matter patents in the US and Europe from respective authorities. The preclinical drug candidates are currently undergoing preparatory steps to meet the regulatory requirements for obtaining permission to conduct clinical phase I studies. Securing the intellectual property rights is an important step in protecting the results of the company’s research and strengthens the projects’ position and commercial potential.Drug candidates IRL942 and IRL1009 stem from IRLAB’s P001 research program and are

2020 Bulkers Ltd. (2020) - Delivery of Bulk Shanghai and commencement of Charter

Hamilton, Bermuda, November 6, 2019 2020 Bulkers is pleased to announce that it today took delivery of the fourth of the eight 208,000 dwt Newcastlemax newbuildings. Two further vessels are expected to be delivered by January 2020, and the remaining two vessels are expected to be delivered by May 2020. The vessel will on November 9, 2019, commence a 11-13 month index-linked timecharter with ST Shipping, a 100% owned subsidiary of Glencore. The index-linked rate reflects a significant premium to a standard Capesize as a function of higher cargo intake and lower fuel consumption.

EQT brings in GIC as minority partner in Anticimex

· EQT brings in GIC, a large institutional investor, in a 9.9% minority stake sale in Anticimex  · With the partnership, Anticimex aims to internationalize the shareholder base and accelerate further growth and expansion in Asia  · EQT remains as controlling owner and continues to support Anticimex in becoming the global leader in preventive pest control The EQT VI fund (“EQT VI”) today announced the decision to bring in GIC as a minority partner through a 9.9% stake sale in Anticimex (“the Company”), in a transaction valuing the Company at approximately EUR 3.6 billion. GIC

Nanoform wins the CPhI Excellence in Pharma Award for Formulation

Helsinki, Finland - Nanoform an innovative medicine enabling nanotechnology company, has won the Excellence in Pharma Award for Formulation at the prestigious CPhI Pharma Awards. Receiving this highly contested prize is an acknowledgement of Nanoform’s commitment to innovation in the industry through its best-in-class CESS[®] nanonization™ technology. Nanoform has been awarded for its work helping international partners find innovative solutions for drug development and delivery. Its multi-patented nanonization processhas the ability to double the number of drug compounds reaching

Digia’s Financial Calendar and Annual General Meeting in 2020

Digia PlcStock exchange release6 November 2019 at 11:00 amDuring the year 2020, Digia Plc will publish the Financial Statement Release, two Business Reviews and Half Year Financial Report as follows: · Financial Statement Release 2019: Friday, 7 February 2020 at 8:00 · Business Review 1-3/2020: Thursday, 7 May 2020 at 8:00 · Half Year Financial Report 1-6/2020: Tuesday, 11 August 2020 at 8:00 · Business Review 1-9/2020: Friday, 30 October 2020 at 15:00 The Annual Report will be available on Digia’s home page on Friday, 21 February 2020. Digia Plc’s Annual General

Comment in relation to Vonovia’s announcement that the conditions precedent to acquire approximately 69.30% of the voting rights and appr 61.19% of the share capital in Hembla have been fulfilled

Hembla AB (publ) (“Hembla”) notes that yesterday, on 5 November 2019, Vonovia SE, through its wholly-owned subsidiary HomeStar InvestCo AB, (“Vonovia”), has announced through a press release that the conditions, including competition clearance by the Swedish Competition Authority, set out in the acquisition agreement entered into between Volvia and Vega Holdco S.à r.l. on 23 September 2019, as further described in Vonovia’s and Hembla’s respective press releases on that day, have been fulfilled. Vonovia further announces that the transaction will be fully completed shortly, and that the

There are no items matching the current filter
There are no more items matching the current filter
Back to top